EC Number |
Natural Substrates |
---|
1.1.1.149 | 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ |
inactive molecule form |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H |
- |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H |
NADPH is preferred to NADH in liver, while the kidney enzyme is specific for NADPH |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H |
progesterone catabolism |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H |
regulation of enzyme expression during pregnancy, the enzyme is required for prostaglandin F2alpha-dependent progesterone down-regulation before parturition, overview |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H |
the aldo-keto reductase, AKR1C23, also shows 20alpha-hydroxysteroid dehydrogenase activity in vivo, enzyme regulation in preovulatory follicles and corpora lutea, overview |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H |
the enzyme activity is highest in women with visceral obesity |
1.1.1.149 | 5alpha-dihydroprogesterone + NADPH + H+ |
- |
1.1.1.149 | cortisol + NADH + H+ |
- |
1.1.1.149 | daunorubicin + NADPH + H+ |
inactivation of the anticancer drug |